Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GFIH Graham-Field Health Prod -- Ignore unavailable to you. Want to Upgrade?

To: hoyasaxa who wrote (53)	11/12/1998 12:23:00 AM
From: Steve Rolfe	Read Replies (1) \| Respond to of 84

Please submit your findings here. We would appreciate it. Graham Field (GFI) After market close, GRAHAM FIELD HEALTH PRODUCTS INC reported 3Q EPS loss of ($0.17) vs $0.13 in the prior year, on revenues of $93.8 mln vs $70.7 mln in 1997. Analysts' mean estimates were a loss of ($0.06), according to First Call. NOTE: 1998 3Q EPS includes one-time charges of $3,348,000 associated with the separation arrangement for the former Chairman of the Board and Chief Executive Officer of Graham-Field. (Reuters 04:28 PM ET 11/11/98) For the full text story, see full story infobeat.com -------------------------------------------------------------------------------- Graham Field (GFI) GRAHAM FIELD HEALTH PRODUCTS INC said it will implement short-term cost cutting programs to save the company $20 mln annually. The new measures are expected to be in place by the end of the 3Q of 1999. The company said it plans to return to profitability in late 1999. Graham-Field said it will change its sales and marketing efforts to revitalize its well-established product brands, and change its commission and incentive programs. (Reuters 04:49 PM ET 11/11/98) For the full text story, see full story infobeat.com